These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 19230892)
21. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans. Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454 [TBL] [Abstract][Full Text] [Related]
22. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile. Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249 [TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-X fifty years after its original discovery. Fellin R; Manzato E Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):4-8. PubMed ID: 30503707 [TBL] [Abstract][Full Text] [Related]
30. The effect of atorvastatin on serum lipoproteins in acromegaly. Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824 [TBL] [Abstract][Full Text] [Related]
31. Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function. Blomhoff JP; Holme R; Sauar J; Gjone E Scand J Clin Lab Invest Suppl; 1978; 150():177-82. PubMed ID: 218275 [TBL] [Abstract][Full Text] [Related]
32. Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg. Wi J; Kim JY; Park S; Kang SM; Jang Y; Chung N; Shim WH; Cho SY; Lee SH Atherosclerosis; 2010 Nov; 213(1):235-40. PubMed ID: 20855072 [TBL] [Abstract][Full Text] [Related]
33. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. Glomset JA; Norum KR; King W J Clin Invest; 1970 Oct; 49(10):1827-37. PubMed ID: 5456796 [TBL] [Abstract][Full Text] [Related]
34. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096 [TBL] [Abstract][Full Text] [Related]
35. Quantitative studies of lipoprotein-X in familial lecithin: cholesterol acyltransferase deficiency and during cholesterol esterification. Ritland S; Gjone E Clin Chim Acta; 1975 Mar; 59(2):109-19. PubMed ID: 1091378 [TBL] [Abstract][Full Text] [Related]
36. LCAT deficiency: molecular and phenotypic characterization of an Italian family. Gigante M; Ranieri E; Cerullo G; Calabresi L; Iolascon A; Assmann G; Morrone L; Pisciotta L; Schena FP; Gesualdo L J Nephrol; 2006; 19(3):375-81. PubMed ID: 16874701 [TBL] [Abstract][Full Text] [Related]
37. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239 [TBL] [Abstract][Full Text] [Related]
38. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study. Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364 [TBL] [Abstract][Full Text] [Related]